 | Up a level |
Galle, P. R., Kim, R. D., Sung, M. W., Harris, W. P., Waldschmidt, D., Cabrera, R., Mueller, U., Nakajima, K., Ishida, T. and El-Khoueiry, A. B. (2020). Updated results of a phase Ib study of regorafenib (REG) plus pembrolizumab (PEMBRO) for first-line treatment of advanced hepatocellular carcinoma (HCC). Ann. Oncol., 31. S. S691 - 2. AMSTERDAM: ELSEVIER. ISSN 1569-8041
Hoeglinger, G., Respondek, G., Stamelou, M., Kurz, C., Josephs, K., Lang, A., Mollenhauer, B., Mueller, U., Nilsson, C., Whitwell, J., Arzberger, T., Gelpi, E., Giese, A., Irwin, D., Meissner, W., Pantelyat, A., van Swieten, J., Troakes, C., Antonini, A., Bhatia, K., Bordelon, Y., Corvol, J. C., Colosimo, C., Dodel, R., Grossman, M., Kassubek, J., Krismer, F., Levin, J., Morris, H., Nestor, P., Oertel, W., Rabinovici, G., Rowe, J., van Eimeren, T., Wenning, G., Yu, J. -T., Golbe, L. I., Litvan, I. and Boxer, A. (2016). Revised clinical diagnostic criteria for progressive supranuclear palsy (PSP). J. Neurochem., 138. S. 364 - 365. HOBOKEN: WILEY-BLACKWELL. ISSN 1471-4159
Kovacs, G. G., Respondek, G., van Eimeren, T., Hoeller, E., Levin, J., Mueller, U., Schwarz, S., Roesler, T. W., Schweyer, K. and Hoeglinger, G. U. (2018). Tauopathies. From molecule to therapy. Nervenarzt, 89 (10). S. 1083 - 1095. NEW YORK: SPRINGER. ISSN 1433-0407